References
- Person AK, Kontoyiannis DP, Alexander BD. Fungal infections in transplant and oncology patients. Infect Dis Clin North Am 2010; 24: 439–459.
- Kontoyiannis DP, Lewis RE. Toward more effective antifungal therapy: the prospects of combination therapy. Br J Haematol 2004; 126: 165–175.
- Wiederhold NP, Lewis RE. The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy. Expert Opin Investig Drugs 2003; 12: 1313–1333.
- Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52: 1.
- Arikan S, Paetznick V, Rex JH. Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother 2002; 46: 3084–3087.
- Kontoyiannis DP, Lewis RE, Sagar N, . Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: an E-test-based strategy. Antimicrob Agents Chemother 2000; 44: 2915–2918.
- Meletiadis J, Mouton JW, Meis JF, . Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol 2001; 39: 4256–4263.
- Eliopoulos GM, Moellering RC Jr. Antimicrobial combinations. Lorian V. Antibiotics in Laboratory Medicine, 4th . Baltimore, MD: Williams and Wilkins, 1996: 330–396.
- Clinical and Laboratory Standards Institute (CLSI). Method for Antifungal Disk Diffusion Testing of Yeasts; Approved Guideline – 2nd. CLSI Document M44-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2009.
- Kontoyiannis DP, Lewis RE, Sagar N, . Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: an E-test-based strategy. Antimicrob Agents Chemother 2000; 44: 2915–2918.
- Lewis RE, Diekema DJ, Messer SA, Pfaller MA, Klepser ME. Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. J Antimicrob Chemother 2002; 49: 345–351.
- Singh N, Limaye AP, Forrest G, . Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation 2006; 81: 320–326.